Zurcher Kantonalbank Zurich Cantonalbank Purchases 1,659 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Stericycle, Inc. (NASDAQ:SRCL) by 9.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 19,737 shares of the business services provider’s stock after acquiring an additional 1,659 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Stericycle were worth $978,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Barclays PLC raised its holdings in Stericycle by 30.6% in the third quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock worth $3,147,000 after buying an additional 16,505 shares during the last quarter. Earnest Partners LLC raised its holdings in Stericycle by 6.6% in the third quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock worth $86,793,000 after buying an additional 120,852 shares during the last quarter. Pathstone Family Office LLC purchased a new position in Stericycle in the third quarter worth about $230,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in Stericycle by 25.7% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 67,860 shares of the business services provider’s stock worth $3,034,000 after buying an additional 13,860 shares during the last quarter. Finally, Impax Asset Management Group plc raised its holdings in Stericycle by 2.3% in the third quarter. Impax Asset Management Group plc now owns 2,991,580 shares of the business services provider’s stock worth $132,805,000 after buying an additional 66,746 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on SRCL. Wells Fargo & Company boosted their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Royal Bank of Canada reissued an “outperform” rating and set a $69.00 price objective on shares of Stericycle in a report on Thursday, March 7th. Truist Financial boosted their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a report on Thursday, February 29th. Finally, Stifel Nicolaus boosted their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Stericycle currently has an average rating of “Hold” and an average price target of $60.80.

Stericycle Stock Performance

Shares of NASDAQ SRCL opened at $46.31 on Monday. The firm has a 50 day moving average of $51.35 and a 200 day moving average of $48.24. The company has a current ratio of 1.11, a quick ratio of 0.94 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $4.30 billion, a price-to-earnings ratio of -210.50, a price-to-earnings-growth ratio of 2.49 and a beta of 1.09. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $57.06.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The business had revenue of $664.90 million during the quarter, compared to analyst estimates of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company’s revenue was down 2.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 earnings per share. On average, research analysts anticipate that Stericycle, Inc. will post 2.32 earnings per share for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.